期刊文献+

依那普利叶酸片治疗H型高血压的临床观察

Clinical Observation of Enalapril Folic Acid Tablets Treatment of H Type Hypertension
下载PDF
导出
摘要 目的:观察患者的高血压依那普利叶酸治疗效果与动态血压监测。方法对我院收治的89例H型高血压患者随机分为对照组(44例)和观察组(45例),给予依那普利和依那普利叶酸治疗,连续8w的双盲治疗,动态血压监测在白天,晚上,24h平均值均在8w的治疗,分析和降低血压和血浆同型半胱氨酸的影响,并观察治疗8w后的心脏和血压昼夜节律。结果①治疗组比对照组在血压监测中要低(P<0.01);②治疗组血浆同型半胱氨酸水平(P<0.01),总有效率高②对照组(P<001)。结论 H型高血压患者依那普利叶酸治疗的临床效果,降低了血压和血浆HCY水平。 Objective Ef ect of ambulatory blood pressure monitoring observation of enalapril folic acid treatment of H type hypertension.Methods 89 patients of H admit ed to our hospital hypertension control group(44 cases)and study group(45 cases),continuous double-blind treatment for 8 W,dynamic blood pressure monitoring during the day,night,24 h mean mean mean at after 8 W treatment respectively,and the analysis of lowering blood pressure and plasma homocysteine(Hcy)ef ect.Results①The dynamic blood pressure study group after treatment were superior to the control group(<0.01);②The levels of plasma Hcy study group after treatment than in the control group(<0.01),total ef iciency is higher than that of the control group(<0.01);study group of systolic and diastolic pressure fluctuations are less,the abnormal rhythm in patients with fewer than the control group(<0.05).Conclusion The clinical ef ect of folic acid type H in hypertension treated with enalapril treatment,reduce blood pressure and plasma HCY level.
作者 谢志红 XIE Zhi-hong(Department of Cardiovascular Medicine,Ganzhou People's Hospital,Ganzhou 341000,Jiangxi,China)
出处 《医学信息(医学与计算机应用)》 2014年第33期199-199,共1页 Medical Information
关键词 H型高血压 依那普利叶酸 血压监测 H type hypertension Enalapril folic acid Blood pressure monitoring
  • 相关文献

参考文献4

二级参考文献24

  • 1金健,高大中.高同型半胱氨酸血症与高血压[J].现代医药卫生,2004,20(20):2115-2117. 被引量:25
  • 2刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2620
  • 3Lonn E,Yusuf S,Arnold MJ,菅鑫妍.血管疾病中叶酸和B族维生素的使用不能降低高半胱氨酸浓度[J].中国处方药,2006,5(6):23-24. 被引量:136
  • 4Mends S,Athanda SB,Naser M,et al.Association between hyper homocysteinaemia and hypertension in Sri Lankans[J].J Int Med Res,1999,27(1):38.
  • 5Rolland PH,Friggi A,Barlatier A,et al.Hyper homocysteine-induced vascular damage in the minipig[J].Circulation,1995,91(4):1161.
  • 6VenturaP,PariaiR,VeriatoC,et.al.Peroxidation indices and totalantioxidation capacity in plasma during hyperhonmcystememia by oraloading[J].metaboUsm,2000,49(2):225.
  • 7HillCH,MehamR,StarcherB.Fibrillin-2 defects impair elastic fiber assembly in a homocysteinemic chick mobdel[J].JoumalofCellularBio chemistry,2001,82(3):491.
  • 8Giuseppe M,Rita F,Michele B,et al.Long-term risk of mortality associated with selective and combined elevation in office,home,and ambulatory blood pressure[J].Hypertension,2006,47(5):846-853.
  • 9Stergiou GS,Mountokalakis TD.Detection of non-dipper hypertensives in clinical practice:does it really matter[J].Nephrol Dial Transplant,1999,14(12):2969-2970.
  • 10Bobrie G,Clerson P,Ménard J,et al.Masked hypertension:a systematic review[J].J Hypertens,2008,26(9):1715-1725.

共引文献125

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部